Chorea associated with gabapentin use in an elderly man

American Journal Geriatric Pharmacotherapy

Volumn 7, Issue 4, 2009, Pages 220-224

  Attupurath, Reji ^a   Aziz, Rehan ^a   Wollman, Daniel ^b   Muralee, Sunanda ^b   Tampi, Rajesh R ^a  

^a RICHMOND UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

chorea; elderly; gabapentin; geriatric

Indexed keywords

CITALOPRAM; CLONAZEPAM; GABAPENTIN; HALOPERIDOL; LIDOCAINE; TRAZODONE;

AGED; ANXIETY DISORDER; ARTICLE; CASE REPORT; CHOREA; COGNITIVE DEFECT; DEMENTIA; DISEASE DURATION; DISEASE EXACERBATION; DRUG DOSE TITRATION; DRUG RESPONSE; DRUG WITHDRAWAL; DYSMETRIA; EVENING DOSAGE; FAMILY HISTORY; GERIATRIC PATIENT; HUMAN; HUNTINGTON CHOREA; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; MOUTH ULCER; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OROFACIAL DYSKINESIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHIATRIC DEPARTMENT; SLEEP DISORDER; SLURRED SPEECH; TREATMENT DURATION; UNITED STATES;

AGED; AMINES; ANALGESICS; ANTI-DYSKINESIA AGENTS; ANXIETY; CHOREA; COGNITION DISORDERS; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HALOPERIDOL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS;

EID: 70249086561     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2009.08.001     Document Type: Article

References (13)

1. Lorincz M.T. Geriatric chorea. Clin Geriatr Med. 22 (2006) 879-897
2. Lorincz M.T. Geriatric chorea. Clin Geriatr Med. 22 (2006) vii
3. García Ruiz P., Gómez-Tortosa E., del Barrio A., et al. Senile chorea: A multicenter prospective study. Acta Neurol Scand. 95 (1997) 180-183
4. Shinotoh H., Calne D.B., Snow B., et al. Normal CAG repeat length in the Huntington's disease gene in senile chorea. Neurology. 44 (1994) 2183-2184
5. Bhidayasiri R., and Truong D.D. Chorea and related disorders [published correction appears in Postgrad Med J. 2004;80:649]. Postgrad Med J. 80 (2004) 527-534
6. Naranjo C.A., Busto U., Sellers E.M., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 30 (1981) 239-245
7. Mink J.W. The basal ganglia and involuntary movements: Impaired inhibition of competing motor patterns. Arch Neurol. 60 (2003) 1365-1368
8. Wichmann T., and Delong R.M. Physiology of the basal ganglia origin. In: Watts R.L., and Koller W.C. (Eds). Movement Disorders: Neurological Principles and Practice (1997), McGraw Hill, Health Professions Division, New York, NY 87-89
9. Twardowschy C.A., Teive H.A., Fernandes A.F., et al. Chorea due to gabapentin monotherapy in a not encephalo-patic patient. Arq Neuropsiquiatr. 66 (2008) 107
10. Bookwalter T., and Gitlin M. Gabapentin-induced neurologic toxicities. Pharmacotherapy. 25 (2005) 1817-1819
11. Taylor C.P. Mechanisms of action of gabapentin. Rev Neurol (Paris). 153 Suppl 1 (1997) w39-45
12. Chudnow R.S., Dewey Jr. R.B., and Lawson C.R. Choreoathetosis as a side effect of gabapentin therapy in severely neurologi-cally impaired patients. Arch Neurol. 54 (1997) 910-912
13. Raju P.M., Walker R.W., and Lee M.A. Dyskinesia induced by gabapentin in idiopathic Parkinson's disease. Mov Disord. 22 (2007) 288-289